+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Guided Tissue & Bone Regeneration Membranes Market - Global Forecast 2026-2032

  • Report

  • 188 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6150580
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Guided Tissue & Bone Regeneration Membranes Market is projected to reach USD 557.27 Million in 2026. It is expected to continue growing at a CAGR of 7.01%, reaching USD 834.86 Million by 2032.

Guided Tissue and Bone Regeneration Membranes: Executive Overview

Guided tissue and bone regeneration membranes are biomaterials used to support selective cellular repopulation during periodontal, oral, maxillofacial, and implant-related procedures. The field includes resorbable and non-resorbable materials, with clinical selection shaped by defect characteristics, handling requirements, healing objectives, and the need for subsequent membrane removal. Adoption is closely connected to dental implant activity, periodontal disease management, reconstructive surgery, clinician training, and evidence-based treatment protocols.

Clinical Integration Is Reshaping Membrane Selection and Use

The landscape is shifting from material-centered purchasing toward procedure-centered treatment planning. Clinicians increasingly assess membrane choice alongside graft materials, fixation methods, defect morphology, soft-tissue management, and patient-specific healing risks. Resorbable solutions can simplify follow-up by avoiding retrieval procedures, while non-resorbable options remain relevant where space maintenance and structural stability are priorities. Regulatory scrutiny, biocompatibility requirements, standardized clinical documentation, and demand for predictable outcomes are also influencing product development and procurement decisions.

Artificial Intelligence Supports Planning, Personalization, and Evidence Generation

Artificial intelligence is increasingly relevant across the clinical workflow rather than as a substitute for biomaterial expertise. Imaging-based tools can assist with three-dimensional assessment of defects, anatomical risk identification, implant positioning, and digital treatment planning. Machine learning may also help clinicians compare patient characteristics with historical outcomes, identify healing-risk patterns, and improve case documentation. In manufacturing and research, AI can support material formulation analysis, process monitoring, image-based histology assessment, and post-market surveillance. Its value depends on representative datasets, clinical validation, explainability, cybersecurity, and integration with established professional judgment.

Regional Dynamics Reflect Differences in Care Access and Clinical Infrastructure

North America combines advanced dental infrastructure, specialist adoption, and strong emphasis on clinical evidence, while reimbursement variation and procedure affordability influence access. Europe benefits from established periodontal and implantology communities, although regulatory and procurement requirements vary across national systems. Asia-Pacific is shaped by expanding urban dental care, growing specialist capacity, and substantial differences between mature and developing healthcare markets. Latin America presents opportunities linked to implantology and private dental care, tempered by uneven access, import dependence, and economic volatility. The Middle East shows concentrated demand in advanced private healthcare and dental centers, whereas Africa is characterized by major differences in specialist availability, laboratory support, affordability, and distribution infrastructure.

Economic and Institutional Groups Reveal Distinct Adoption Conditions

ASEAN markets combine rapidly developing private dental services with varied regulatory systems, training capacity, and import procedures. BRICS countries reflect diverse healthcare structures, domestic manufacturing capabilities, and access conditions, making localized clinical education and distribution important. The European Union benefits from cross-border scientific collaboration and common regulatory principles, while national reimbursement and procurement practices remain influential. G7 markets generally emphasize advanced clinical protocols, quality systems, and evidence generation. GCC countries often show concentrated investment in specialist healthcare and internationally trained clinicians. NATO members span highly diverse dental systems, but many support sophisticated medical-device oversight, professional education, and cross-border clinical collaboration.

Country-Level Priorities Range from Innovation Capacity to Access Expansion

Australia emphasizes specialist dentistry, clinical governance, and geographically uneven access. Brazil combines a substantial dental professional base with regional disparities and affordability considerations. Canada’s publicly and privately funded care mix creates differences in access across provinces and population groups. China is characterized by expanding dental infrastructure, urban concentration, and strengthening domestic medical-device capabilities. France, Germany, Italy, and Spain maintain established dental and implantology practices, with procurement, reimbursement, and regulatory implementation shaping adoption. India combines a large clinical workforce and growing private care with pronounced variation in affordability and infrastructure. Japan and South Korea have advanced healthcare and technology ecosystems, alongside strong expectations for quality and clinical performance. Mexico reflects expanding private dental services but uneven regional access. Russia’s use environment is influenced by healthcare-system variation, supply considerations, and regulatory conditions. The United Kingdom emphasizes evidence-based practice, professional standards, and public-private access differences. The United States remains a major center for specialist care, research, advanced dental procedures, and product evaluation, while insurance coverage and treatment affordability continue to affect utilization.

Industry Leaders Should Link Evidence, Workflow Fit, and Access Strategy

Leaders should prioritize clinically meaningful differentiation, including predictable handling, appropriate barrier function, biocompatibility, and compatibility with regenerative protocols. Evidence programs should use well-defined endpoints, transparent follow-up, and patient-relevant outcomes across periodontal, implant, and reconstructive applications. Commercial teams should segment strategies by procedure, clinician experience, care setting, and regional regulatory pathway rather than relying on a single global approach. Digital planning partnerships, clinician education, standardized protocols, and decision-support tools can improve appropriate use. Companies should also strengthen supply resilience, post-market surveillance, training for complication management, and affordability-oriented access models while maintaining rigorous quality and compliance controls.

Methodology: Evidence-Led Assessment of Clinical and Market Drivers

This executive summary uses a structured synthesis of the supplied market definition and established evidence categories relevant to guided tissue and bone regeneration membranes. The assessment considers membrane materials, clinical applications, procedural workflows, regulatory and quality requirements, provider capabilities, regional healthcare conditions, professional education, and technology adoption. Regional, group, and country perspectives are integrated qualitatively to identify differences in infrastructure, access, specialization, and operating conditions. Artificial intelligence is evaluated by its documented or plausible role in planning, research, manufacturing, and monitoring, without treating emerging capabilities as validated clinical outcomes. No market estimates, shares, forecasts, or company-specific claims are included.

The Winning Position Will Combine Regenerative Performance with Practical Delivery

Guided tissue and bone regeneration membranes are advancing within a broader shift toward personalized, digitally supported, and evidence-based dental and reconstructive care. Success will depend not only on biomaterial performance, but also on ease of use, procedural integration, clinician confidence, regulatory discipline, and patient access. Organizations that connect robust clinical evidence with regional execution, responsible digital innovation, resilient supply, and effective education will be better positioned to support predictable regenerative treatment across diverse healthcare environments.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Guided Tissue & Bone Regeneration Membranes Market, by Material Type
7.1. Introduction
7.2. Non-Resorbable
7.2.1. Dense Polytetrafluoroethylene
7.2.2. Expanded Polytetrafluoroethylene
7.2.3. Titanium Reinforced Polytetrafluoroethylene
7.3. Resorbable
7.3.1. Collagen
7.3.1.1. Bovine
7.3.1.2. Equine
7.3.1.3. Porcine
7.3.2. Synthetic
7.3.2.1. Polycaprolactone
7.3.2.2. Polyglycolic Acid
7.3.2.3. Polylactic Acid
8. Guided Tissue & Bone Regeneration Membranes Market, by Application
8.1. Introduction
8.2. Guided Bone Regeneration
8.3. Guided Tissue Regeneration
9. Guided Tissue & Bone Regeneration Membranes Market, by End User
9.1. Introduction
9.2. Ambulatory Surgical Centers
9.3. Dental Clinics
9.4. Hospitals
9.5. Specialty Clinics
10. Guided Tissue & Bone Regeneration Membranes Market, by Source
10.1. Introduction
10.2. Animal Derived
10.2.1. Bovine
10.2.2. Equine
10.2.3. Porcine
10.3. Synthetic
10.3.1. Polycaprolactone
10.3.2. Polyglycolic Acid
10.3.3. Polylactic Acid
10.3.4. Polytetrafluoroethylene
11. Guided Tissue & Bone Regeneration Membranes Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Guided Tissue & Bone Regeneration Membranes Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Guided Tissue & Bone Regeneration Membranes Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. ACE Surgical Supply Company, Inc.
15.2. BEGO GmbH & Co. KG
15.3. BioHorizons, Inc.
15.4. Bioteck S.P.A.
15.5. Botiss biomaterials GmbH
15.6. Cologenesis Healthcare Private Limited
15.7. DENTSPLY SIRONA Inc.
15.8. Geistlich Pharma AG
15.9. Integra LifeSciences Holdings Corporation
15.10. Keystone Dental, Inc.
15.11. Neoss Limited
15.12. Nobel Biocare Services AG
15.13. OraPharma, Inc.
15.14. Straumann Holding AG
15.15. Sunstar Suisse S.A.
15.16. Yantai Zhenghai Bio-tech Co., Ltd.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Guided Tissue & Bone Regeneration Membranes Market, Years Considered for the Study
FIGURE 2. Global Guided Tissue & Bone Regeneration Membranes Market, Research Design
FIGURE 3. Global Guided Tissue & Bone Regeneration Membranes Market, Research Framework
FIGURE 4. Global Guided Tissue & Bone Regeneration Membranes Market, Data Triangulation
FIGURE 5. Global Guided Tissue & Bone Regeneration Membranes Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Guided Tissue & Bone Regeneration Membranes Market Size, by Material Type, 2025 vs 2032 (%)
FIGURE 7. Global Guided Tissue & Bone Regeneration Membranes Market Size, by Material Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Guided Tissue & Bone Regeneration Membranes Market Size, by Application, 2025 vs 2032 (%)
FIGURE 9. Global Guided Tissue & Bone Regeneration Membranes Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Guided Tissue & Bone Regeneration Membranes Market Size, by End User, 2025 vs 2032 (%)
FIGURE 11. Global Guided Tissue & Bone Regeneration Membranes Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Guided Tissue & Bone Regeneration Membranes Market Size, by Source, 2025 vs 2032 (%)
FIGURE 13. Global Guided Tissue & Bone Regeneration Membranes Market Size, by Source, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Guided Tissue & Bone Regeneration Membranes Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Guided Tissue & Bone Regeneration Membranes Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Guided Tissue & Bone Regeneration Membranes Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Guided Tissue & Bone Regeneration Membranes Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Guided Tissue & Bone Regeneration Membranes Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Guided Tissue & Bone Regeneration Membranes Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Guided Tissue & Bone Regeneration Membranes Market Segmentation & Coverage
TABLE 2. Global Guided Tissue & Bone Regeneration Membranes Market Size, 2017-2032 (USD Million)
TABLE 3. Global Guided Tissue & Bone Regeneration Membranes Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 4. Global Non-Resorbable Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Non-Resorbable Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Non-Resorbable Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Dense Polytetrafluoroethylene Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Dense Polytetrafluoroethylene Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Dense Polytetrafluoroethylene Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Expanded Polytetrafluoroethylene Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Expanded Polytetrafluoroethylene Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Expanded Polytetrafluoroethylene Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Titanium Reinforced Polytetrafluoroethylene Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Titanium Reinforced Polytetrafluoroethylene Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Titanium Reinforced Polytetrafluoroethylene Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Resorbable Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Resorbable Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Resorbable Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Collagen Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Collagen Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Collagen Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Bovine Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Bovine Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Bovine Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Equine Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Equine Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Equine Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Porcine Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Porcine Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Porcine Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Synthetic Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Synthetic Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Synthetic Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Polycaprolactone Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Polycaprolactone Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Polycaprolactone Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Polyglycolic Acid Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Polyglycolic Acid Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Polyglycolic Acid Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Polylactic Acid Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Polylactic Acid Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Polylactic Acid Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Guided Tissue & Bone Regeneration Membranes Market Size, by Application, 2017-2032 (USD Million)
TABLE 44. Global Guided Bone Regeneration Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Guided Bone Regeneration Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Guided Bone Regeneration Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Guided Tissue Regeneration Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Guided Tissue Regeneration Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Guided Tissue Regeneration Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Guided Tissue & Bone Regeneration Membranes Market Size, by End User, 2017-2032 (USD Million)
TABLE 51. Global Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Dental Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Dental Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Dental Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Specialty Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Specialty Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Specialty Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Guided Tissue & Bone Regeneration Membranes Market Size, by Source, 2017-2032 (USD Million)
TABLE 64. Global Animal Derived Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Animal Derived Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Animal Derived Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Bovine Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Bovine Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Bovine Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Equine Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Equine Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Equine Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Porcine Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Porcine Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Porcine Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Synthetic Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Synthetic Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Synthetic Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global Polycaprolactone Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Global Polycaprolactone Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. Global Polycaprolactone Market Size, by Country, 2017-2032 (USD Million)
TABLE 82. Global Polyglycolic Acid Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Global Polyglycolic Acid Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. Global Polyglycolic Acid Market Size, by Country, 2017-2032 (USD Million)
TABLE 85. Global Polylactic Acid Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Global Polylactic Acid Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. Global Polylactic Acid Market Size, by Country, 2017-2032 (USD Million)
TABLE 88. Global Polytetrafluoroethylene Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Global Polytetrafluoroethylene Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. Global Polytetrafluoroethylene Market Size, by Country, 2017-2032 (USD Million)
TABLE 91. Global Guided Tissue & Bone Regeneration Membranes Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Asia-Pacific Guided Tissue & Bone Regeneration Membranes Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Asia-Pacific Guided Tissue & Bone Regeneration Membranes Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 94. Asia-Pacific Guided Tissue & Bone Regeneration Membranes Market Size, by Non-Resorbable, 2017-2032 (USD Million)
TABLE 95. Asia-Pacific Guided Tissue & Bone Regeneration Membranes Market Size, by Resorbable, 2017-2032 (USD Million)
TABLE 96. Asia-Pacific Guided Tissue & Bone Regeneration Membranes Market Size, by Collagen, 2017-2032 (USD Million)
TABLE 97. Asia-Pacific Guided Tissue & Bone Regeneration Membranes Market Size, by Synthetic, 2017-2032 (USD Million)
TABLE 98. Asia-Pacific Guided Tissue & Bone Regeneration Membranes Market Size, by Application, 2017-2032 (USD Million)
TABLE 99. Asia-Pacific Guided Tissue & Bone Regeneration Membranes Market Size, by End User, 2017-2032 (USD Million)
TABLE 100. Asia-Pacific Guided Tissue & Bone Regeneration Membranes Market Size, by Source, 2017-2032 (USD Million)
TABLE 101. Asia-Pacific Guided Tissue & Bone Regeneration Membranes Market Size, by Animal Derived, 2017-2032 (USD Million)
TABLE 102. Asia-Pacific Guided Tissue & Bone Regeneration Membranes Market Size, by Synthetic, 2017-2032 (USD Million)
TABLE 103. North America Guided Tissue & Bone Regeneration Membranes Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. North America Guided Tissue & Bone Regeneration Membranes Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 105. North America Guided Tissue & Bone Regeneration Membranes Market Size, by Non-Resorbable, 2017-2032 (USD Million)
TABLE 106. North America Guided Tissue & Bone Regeneration Membranes Market Size, by Resorbable, 2017-2032 (USD Million)
TABLE 107. North America Guided Tissue & Bone Regeneration Membranes Market Size, by Collagen, 2017-2032 (USD Million)
TABLE 108. North America Guided Tissue & Bone Regeneration Membranes Market Size, by Synthetic, 2017-2032 (USD Million)
TABLE 109. North America Guided Tissue & Bone Regeneration Membranes Market Size, by Application, 2017-2032 (USD Million)
TABLE 110. North America Guided Tissue & Bone Regeneration Membranes Market Size, by End User, 2017-2032 (USD Million)
TABLE 111. North America Guided Tissue & Bone Regeneration Membranes Market Size, by Source, 2017-2032 (USD Million)
TABLE 112. North America Guided Tissue & Bone Regeneration Membranes Market Size, by Animal Derived, 2017-2032 (USD Million)
TABLE 113. North America Guided Tissue & Bone Regeneration Membranes Market Size, by Synthetic, 2017-2032 (USD Million)
TABLE 114. Latin America Guided Tissue & Bone Regeneration Membranes Market Size, by Region, 2017-2032 (USD Million)
TABLE 115. Latin America Guided Tissue & Bone Regeneration Membranes Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 116. Latin America Guided Tissue & Bone Regeneration Membranes Market Size, by Non-Resorbable, 2017-2032 (USD Million)
TABLE 117. Latin America Guided Tissue & Bone Regeneration Membranes Market Size, by Resorbable, 2017-2032 (USD Million)
TABLE 118. Latin America Guided Tissue & Bone Regeneration Membranes Market Size, by Collagen, 2017-2032 (USD Million)
TABLE 119. Latin America Guided Tissue & Bone Regeneration Membranes Market Size, by Synthetic, 2017-2032 (USD Million)
TABLE 120. Latin America Guided Tissue & Bone Regeneration Membranes Market Size, by Application, 2017-2032 (USD Million)
TABLE 121. Latin America Guided Tissue & Bone Regeneration Membranes Market Size, by End User, 2017-2032 (USD Million)
TABLE 122. Latin America Guided Tissue & Bone Regeneration Membranes Market Size, by Source, 2017-2032 (USD Million)
TABLE 123. Latin America Guided Tissue & Bone Regeneration Membranes Market Size, by Animal Derived, 2017-2032 (USD Million)
TABLE 124. Latin America Guided Tissue & Bone Regeneration Membranes Market Size, by Synthetic, 2017-2032 (USD Million)
TABLE 125. Europe Guided Tissue & Bone Regeneration Membranes Market Size, by Region, 2017-2032 (USD Million)
TABLE 126. Europe Guided Tissue & Bone Regeneration Membranes Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 127. Europe Guided Tissue & Bone Regeneration Membranes Market Size, by Non-Resorbable, 2017-2032 (USD Million)
TABLE 128. Europe Guided Tissue & Bone Regeneration Membranes Market Size, by Resorbable, 2017-2032 (USD Million)
TABLE 129. Europe Guided Tissue & Bone Regeneration Membranes Market Size, by Collagen, 2017-2032 (USD Million)
TABLE 130. Europe Guided Tissue & Bone Regeneration Membranes Market Size, by Synthetic, 2017-2032 (USD Million)
TABLE 131. Europe Guided Tissue & Bone Regeneration Membranes Market Size, by Application, 2017-2032 (USD Million)
TABLE 132. Europe Guided Tissue & Bone Regeneration Membranes Market Size, by End User, 2017-2032 (USD Million)
TABLE 133. Europe Guided Tissue & Bone Regeneration Membranes Market Size, by Source, 2017-2032 (USD Million)
TABLE 134. Europe Guided Tissue & Bone Regeneration Membranes Market Size, by Animal Derived, 2017-2032 (USD Million)
TABLE 135. Europe Guided Tissue & Bone Regeneration Membranes Market Size, by Synthetic, 2017-2032 (USD Million)
TABLE 136. Middle East Guided Tissue & Bone Regeneration Membranes Market Size, by Region, 2017-2032 (USD Million)
TABLE 137. Middle East Guided Tissue & Bone Regeneration Membranes Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 138. Middle East Guided Tissue & Bone Regeneration Membranes Market Size, by Non-Resorbable, 2017-2032 (USD Million)
TABLE 139. Middle East Guided Tissue & Bone Regeneration Membranes Market Size, by Resorbable, 2017-2032 (USD Million)
TABLE 140. Middle East Guided Tissue & Bone Regeneration Membranes Market Size, by Collagen, 2017-2032 (USD Million)
TABLE 141. Middle East Guided Tissue & Bone Regeneration Membranes Market Size, by Synthetic, 2017-2032 (USD Million)
TABLE 142. Middle East Guided Tissue & Bone Regeneration Membranes Market Size, by Application, 2017-2032 (USD Million)
TABLE 143. Middle East Guided Tissue & Bone Regeneration Membranes Market Size, by End User, 2017-2032 (USD Million)
TABLE 144. Middle East Guided Tissue & Bone Regeneration Membranes Market Size, by Source, 2017-2032 (USD Million)
TABLE 145. Middle East Guided Tissue & Bone Regeneration Membranes Market Size, by Animal Derived, 2017-2032 (USD Million)
TABLE 146. Middle East Guided Tissue & Bone Regeneration Membranes Market Size, by Synthetic, 2017-2032 (USD Million)
TABLE 147. Africa Guided Tissue & Bone Regeneration Membranes Market Size, by Region, 2017-2032 (USD Million)
TABLE 148. Africa Guided Tissue & Bone Regeneration Membranes Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 149. Africa Guided Tissue & Bone Regeneration Membranes Market Size, by Non-Resorbable, 2017-2032 (USD Million)
TABLE 150. Africa Guided Tissue & Bone Regeneration Membranes Market Size, by Resorbable, 2017-2032 (USD Million)
TABLE 151. Africa Guided Tissue & Bone Regeneration Membranes Market Size, by Collagen, 2017-2032 (USD Million)
TABLE 152. Africa Guided Tissue & Bone Regeneration Membranes Market Size, by Synthetic, 2017-2032 (USD Million)
TABLE 153. Africa Guided Tissue & Bone Regeneration Membranes Market Size, by Application, 2017-2032 (USD Million)
TABLE 154. Africa Guided Tissue & Bone Regeneration Membranes Market Size, by End User, 2017-2032 (USD Million)
TABLE 155. Africa Guided Tissue & Bone Regeneration Membranes Market Size, by Source, 2017-2032 (USD Million)
TABLE 156. Africa Guided Tissue & Bone Regeneration Membranes Market Size, by Animal Derived, 2017-2032 (USD Million)
TABLE 157. Africa Guided Tissue & Bone Regeneration Membranes Market Size, by Synthetic, 2017-2032 (USD Million)
TABLE 158. Global Guided Tissue & Bone Regeneration Membranes Market Size, by Group, 2017-2032 (USD Million)
TABLE 159. ASEAN Guided Tissue & Bone Regeneration Membranes Market Size, by Group, 2017-2032 (USD Million)
TABLE 160. ASEAN Guided Tissue & Bone Regeneration Membranes Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 161. ASEAN Guided Tissue & Bone Regeneration Membranes Market Size, by Non-Resorbable, 2017-2032 (USD Million)
TABLE 162. ASEAN Guided Tissue & Bone Regeneration Membranes Market Size, by Resorbable, 2017-2032 (USD Million)
TABLE 163. ASEAN Guided Tissue & Bone Regeneration Membranes Market Size, by Collagen, 2017-2032 (USD Million)
TABLE 164. ASEAN Guided Tissue & Bone Regeneration Membranes Market Size, by Synthetic, 2017-2032 (USD Million)
TABLE 165. ASEAN Guided Tissue & Bone Regeneration Membranes Market Size, by Application, 2017-2032 (USD Million)
TABLE 166. ASEAN Guided Tissue & Bone Regeneration Membranes Market Size, by End User, 2017-2032 (USD Million)
TABLE 167. ASEAN Guided Tissue & Bone Regeneration Membranes Market Size, by Source, 2017-2032 (USD Million)
TABLE 168. ASEAN Guided Tissue & Bone Regeneration Membranes Market Size, by Animal Derived, 2017-2032 (USD Million)
TABLE 169. ASEAN Guided Tissue & Bone Regeneration Membranes Market Size, by Synthetic, 2017-2032 (USD Million)
TABLE 170. GCC Guided Tissue & Bone Regeneration Membranes Market Size, by Group, 2017-2032 (USD Million)
TABLE 171. GCC Guided Tissue & Bone Regeneration Membranes Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 172. GCC Guided Tissue & Bone Regeneration Membranes Market Size, by Non-Resorbable, 2017-2032 (USD Million)
TABLE 173. GCC Guided Tissue & Bone Regeneration Membranes Market Size, by Resorbable, 2017-2032 (USD Million)
TABLE 174. GCC Guided Tissue & Bone Regeneration Membranes Market Size, by Collagen, 2017-2032 (USD Million)
TABLE 175. GCC Guided Tissue & Bone Regeneration Membranes Market Size, by Synthetic, 2017-2032 (USD Million)
TABLE 176. GCC Guided Tissue & Bone Regeneration Membranes Market Size, by Application, 2017-2032 (USD Million)
TABLE 177. GCC Guided Tissue & Bone Regeneration Membranes Market Size, by End User, 2017-2032 (USD Million)
TABLE 178. GCC Guided Tissue & Bone Regeneration Membranes Market Size, by Source, 2017-2032 (USD Million)
TABLE 179. GCC Guided Tissue & Bone Regeneration Membranes Market Size, by Animal Derived, 2017-2032 (USD Million)
TABLE 180. GCC Guided Tissue & Bone Regeneration Membranes Market Size, by Synthetic, 2017-2032 (USD Million)
TABLE 181. European Union Guided Tissue & Bone Regeneration Membranes Market Size, by Group, 2017-2032 (USD Million)
TABLE 182. European Union Guided Tissue & Bone Regeneration Membranes Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 183. European Union Guided Tissue & Bone Regeneration Membranes Market Size, by Non-Resorbable, 2017-2032 (USD Million)
TABLE 184. European Union Guided Tissue & Bone Regeneration Membranes Market Size, by Resorbable, 2017-2032 (USD Million)
TABLE 185. European Union Guided Tissue & Bone Regeneration Membranes Market Size, by Collagen, 2017-2032 (USD Million)
TABLE 186. European Union Guided Tissue & Bone Regeneration Membranes Market Size, by Synthetic, 2017-2032 (USD Million)
TABLE 187. European Union Guided Tissue & Bone Regeneration Membranes Market Size, by Application, 2017-2032 (USD Million)
TABLE 188. European Union Guided Tissue & Bone Regeneration Membranes Market Size, by End User, 2017-2032 (USD Million)
TABLE 189. European Union Guided Tissue & Bone Regeneration Membranes Market Size, by Source, 2017-2032 (USD Million)
TABLE 190. European Union Guided Tissue & Bone Regeneration Membranes Market Size, by Animal Derived, 2017-2032 (USD Million)
TABLE 191. European Union Guided Tissue & Bone Regeneration Membranes Market Size, by Synthetic, 2017-2032 (USD Million)
TABLE 192. BRICS Guided Tissue & Bone Regeneration Membranes Market Size, by Group, 2017-2032 (USD Million)
TABLE 193. BRICS Guided Tissue & Bone Regeneration Membranes Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 194. BRICS Guided Tissue & Bone Regeneration Membranes Market Size, by Non-Resorbable, 2017-2032 (USD Million)
TABLE 195. BRICS Guided Tissue & Bone Regeneration Membranes Market Size, by Resorbable, 2017-2032 (USD Million)
TABLE 196. BRICS Guided Tissue & Bone Regeneration Membranes Market Size, by Collagen, 2017-2032 (USD Million)
TABLE 197. BRICS Guided Tissue & Bone Regeneration Membranes Market Size, by Synthetic, 2017-2032 (USD Million)
TABLE 198. BRICS Guided Tissue & Bone Regeneration Membranes Market Size, by Application, 2017-2032 (USD Million)
TABLE 199. BRICS Guided Tissue & Bone Regeneration Membranes Market Size, by End User, 2017-2032 (USD Million)
TABLE 200. BRICS Guided Tissue & Bone Regeneration Membranes Market Size, by Source, 2017-2032 (USD Million)
TABLE 201. BRICS Guided Tissue & Bone Regeneration Membranes Market Size, by Animal Derived, 2017-2032 (USD Million)
TABLE 202. BRICS Guided Tissue & Bone Regeneration Membranes Market Size, by Synthetic, 2017-2032 (USD Million)
TABLE 203. G7 Guided Tissue & Bone Regeneration Membranes Market Size, by Group, 2017-2032 (USD Million)
TABLE 204. G7 Guided Tissue & Bone Regeneration Membranes Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 205. G7 Guided Tissue & Bone Regeneration Membranes Market Size, by Non-Resorbable, 2017-2032 (USD Million)
TABLE 206. G7 Guided Tissue & Bone Regeneration Membranes Market Size, by Resorbable, 2017-2032 (USD Million)
TABLE 207. G7 Guided Tissue & Bone Regeneration Membranes Market Size, by Collagen, 2017-2032 (USD Million)
TABLE 208. G7 Guided Tissue & Bone Regeneration Membranes Market Size, by Synthetic, 2017-2032 (USD Million)
TABLE 209. G7 Guided Tissue & Bone Regeneration Membranes Market Size, by Application, 2017-2032 (USD Million)
TABLE 210. G7 Guided Tissue & Bone Regeneration Membranes Market Size, by End User, 2017-2032 (USD Million)
TABLE 211. G7 Guided Tissue & Bone Regeneration Membranes Market Size, by Source, 2017-2032 (USD Million)
TABLE 212. G7 Guided Tissue & Bone Regeneration Membranes Market Size, by Animal Derived, 2017-2032 (USD Million)
TABLE 213. G7 Guided Tissue & Bone Regeneration Membranes Market Size, by Synthetic, 2017-2032 (USD Million)
TABLE 214. NATO Guided Tissue & Bone Regeneration Membranes Market Size, by Group, 2017-2032 (USD Million)
TABLE 215. NATO Guided Tissue & Bone Regeneration Membranes Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 216. NATO Guided Tissue & Bone Regeneration Membranes Market Size, by Non-Resorbable, 2017-2032 (USD Million)
TABLE 217. NATO Guided Tissue & Bone Regeneration Membranes Market Size, by Resorbable, 2017-2032 (USD Million)
TABLE 218. NATO Guided Tissue & Bone Regeneration Membranes Market Size, by Collagen, 2017-2032 (USD Million)
TABLE 219. NATO Guided Tissue & Bone Regeneration Membranes Market Size, by Synthetic, 2017-2032 (USD Million)
TABLE 220. NATO Guided Tissue & Bone Regeneration Membranes Market Size, by Application, 2017-2032 (USD Million)
TABLE 221. NATO Guided Tissue & Bone Regeneration Membranes Market Size, by End User, 2017-2032 (USD Million)
TABLE 222. NATO Guided Tissue & Bone Regeneration Membranes Market Size, by Source, 2017-2032 (USD Million)
TABLE 223. NATO Guided Tissue & Bone Regeneration Membranes Market Size, by Animal Derived, 2017-2032 (USD Million)
TABLE 224. NATO Guided Tissue & Bone Regeneration Membranes Market Size, by Synthetic, 2017-2032 (USD Million)
TABLE 225. Global Guided Tissue & Bone Regeneration Membranes Market Size, by Country, 2017-2032 (USD Million)
TABLE 226. United States Guided Tissue & Bone Regeneration Membranes Market Size, 2017-2032 (USD Million)
TABLE 227. United States Guided Tissue & Bone Regeneration Membranes Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 228. United States Guided Tissue & Bone Regeneration Membranes Market Size, by Non-Resorbable, 2017-2032 (USD Million)
TABLE 229. United States Guided Tissue & Bone Regeneration Membranes Market Size, by Resorbable, 2017-2032 (USD Million)
TABLE 230. United States Guided Tissue & Bone Regeneration Membranes Market Size, by Collagen, 2017-2032 (USD Million)
TABLE 231. United States Guided Tissue & Bone Regeneration Membranes Market Size, by Synthetic, 2017-2032 (USD Million)
TABLE 232. United States Guided Tissue & Bone Regeneration Membranes Market Size, by Application, 2017-2032 (USD Million)
TABLE 233. United States Guided Tissue & Bone Regeneration Membranes Market Size, by End User, 2017-2032 (USD Million)
TABLE 234. United States Guided Tissue & Bone Regeneration Membranes Market Size, by Source, 2017-2032 (USD Million)
TABLE 235. United States Guided Tissue & Bone Regeneration Membranes Market Size, by Animal Derived, 2017-2032 (USD Million)
TABLE 236. United States Guided Tissue & Bone Regeneration Membranes Market Size, by Synthetic, 2017-2032 (USD Million)
TABLE 237. Canada Guided Tissue & Bone Regeneration Membranes Market Size, 2017-2032 (USD Million)
TABLE 238. Canada Guided Tissue & Bone Regeneration Membranes Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 239. Canada Guided Tissue & Bone Regeneration Membranes Market Size, by Non-Resorbable, 2017-2032 (USD Million)
TABLE 240. Canada Guided Tissue & Bone Regeneration Membranes Market Size, by Resorbable, 2017-2032 (USD Million)
TABLE 241. Canada Guided Tissue & Bone Regeneration Membranes Market Size, by Collagen, 2017-2032 (USD Million)
TABLE 242. Canada Guided Tissue & Bone Regeneration Membranes Market Size, by Synthetic, 2017-2032 (USD Million)
TABLE 243. Canada Guided Tissue & Bone Regeneration Membranes Market Size, by Application, 2017-2032 (USD Million)
TABLE 244. Canada Guided Tissue & Bone Regeneration Membranes Market Size, by End User, 2017-2032 (USD Million)
TABLE 245. Canada Guided Tissue & Bone Regeneration Membranes Market Size, by Source, 2017-2032 (USD Million)
TABLE 246. Canada Guided Tissue & Bone Regeneration Membranes Market Size, by Animal Derived, 2017-2032 (USD Million)
TABLE 247. Canada Guided Tissue & Bone Regeneration Membranes Market Size, by Synthetic, 2017-2032 (USD Million)
TABLE 248. Mexico Guided Tissue & Bone Regeneration Membranes Market Size, 2017-2032 (USD Million)
TABLE 249. Mexico Guided Tissue & Bone Regeneration Membranes Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 250. Mexico Guided Tissue & Bone Regeneration Membranes Market Size, by Non-Resorbable, 2017-2032 (USD Million)
TABLE 251. Mexico Guided Tissue & Bone Regeneration Membranes Market Size, by Resorbable, 2017-2032 (USD Million)
TABLE 252. Mexico Guided Tissue & Bone Regeneration Membranes Market Size, by Collagen, 2017-2032 (USD Million)
TABLE 253. Mexico Guided Tissue & Bone Regeneration Membranes Market Size, by Synthetic, 2017-2032 (USD Million)
TABLE 254. Mexico Guided Tissue & Bone Regeneration Membranes Market Size, by Application, 2017-2032 (USD Million)
TABLE 255. Mexico Guided Tissue & Bone Regeneration Membranes Market Size, by End User, 2017-2032 (USD Million)
TABLE 256. Mexico Guided Tissue & Bone Regeneration Membranes Market Size, by Source, 2017-2032 (USD Million)
TABLE 257. Mexico Guided Tissue & Bone Regeneration Membranes Market Size, by Animal Derived, 2017-2032 (USD Million)
TABLE 258. Mexico Guided Tissue & Bone Regeneration Membranes Market Size, by Synthetic, 2017-2032 (USD Million)
TABLE 259. Brazil Guided Tissue & Bone Regeneration Membranes Market Size, 2017-2032 (USD Million)
TABLE 260. Brazil Guided Tissue & Bone Regeneration Membranes Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 261. Brazil Guided Tissue & Bone Regeneration Membranes Market Size, by Non-Resorbable, 2017-2032 (USD Million)
TABLE 262. Brazil Guided Tissue & Bone Regeneration Membranes Market Size, by Resorbable, 2017-2032 (USD Million)
TABLE 263. Brazil Guided Tissue & Bone Regeneration Membranes Market Size, by Collagen, 2017-2032 (USD Million)
TABLE 264. Brazil Guided Tissue & Bone Regeneration Membranes Market Size, by Synthetic, 2017-2032 (USD Million)
TABLE 265. Brazil Guided Tissue & Bone Regeneration Membranes Market Size, by Application, 2017-2032 (USD Million)
TABLE 266. Brazil Guided Tissue & Bone Regeneration Membranes Market Size, by End User, 2017-2032 (USD Million)
TABLE 267. Brazil Guided Tissue & Bone Regeneration Membranes Market Size, by Source, 2017-2032 (USD Million)
TABLE 268. Brazil Guided Tissue & Bone Regeneration Membranes Market Size, by Animal Derived, 2017-2032 (USD Million)
TABLE 269. Brazil Guided Tissue & Bone Regeneration Membranes Market Size, by Synthetic, 2017-2032 (USD Million)
TABLE 270. United Kingdom Guided Tissue & Bone Regeneration Membranes Market Size, 2017-2032 (USD Million)
TABLE 271. United Kingdom Guided Tissue & Bone Regeneration Membranes Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 272. United Kingdom Guided Tissue & Bone Regeneration Membranes Market Size, by Non-Resorbable, 2017-2032 (USD Million)
TABLE 273. United Kingdom Guided Tissue & Bone Regeneration Membranes Market Size, by Resorbable, 2017-2032 (USD Million)
TABLE 274. United Kingdom Guided Tissue & Bone Regeneration Membranes Market Size, by Collagen, 2017-2032 (USD Million)
TABLE 275. United Kingdom Guided Tissue & Bone Regeneration Membranes Market Size, by Synthetic, 2017-2032 (USD Million)
TABLE 276. United Kingdom Guided Tissue & Bone Regeneration Membranes Market Size, by Application, 2017-2032 (USD Million)
TABLE 277. United Kingdom Guided Tissue & Bone Regeneration Membranes Market Size, by End User, 2017-2032 (USD Million)
TABLE 278. United Kingdom Guided Tissue & Bone Regeneration Membranes Market Size, by Source, 2017-2032 (USD Million)
TABLE 279. United Kingdom Guided Tissue & Bone Regeneration Membranes Market Size, by Animal Derived, 2017-2032 (USD Million)
TABLE 280. United Kingdom Guided Tissue & Bone Regeneration Membranes Market Size, by Synthetic, 2017-2032 (USD Million)
TABLE 281. Germany Guided Tissue & Bone Regeneration Membranes Market Size, 2017-2032 (USD Million)
TABLE 282. Germany Guided Tissue & Bone Regeneration Membranes Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 283. Germany Guided Tissue & Bone Regeneration Membranes Market Size, by Non-Resorbable, 2017-2032 (USD Million)
TABLE 284. Germany Guided Tissue & Bone Regeneration Membranes Market Size, by Resorbable, 2017-2032 (USD Million)
TABLE 285. Germany Guided Tissue & Bone Regeneration Membranes Market Size, by Collagen, 2017-2032 (USD Million)
TABLE 286. Germany Guided Tissue & Bone Regeneration Membranes Market Size, by Synthetic, 2017-2032 (USD Million)
TABLE 287. Germany Guided Tissue & Bone Regeneration Membranes Market Size, by Application, 2017-2032 (USD Million)
TABLE 288. Germany Guided Tissue & Bone Regeneration Membranes Market Size, by End User, 2017-2032 (USD Million)
TABLE 289. Germany Guided Tissue & Bone Regeneration Membranes Market Size, by Source, 2017-2032 (USD Million)
TABLE 290. Germany Guided Tissue & Bone Regeneration Membranes Market Size, by Animal Derived, 2017-2032 (USD Million)
TABLE 291. Germany Guided Tissue & Bone Regeneration Membranes Market Size, by Synthetic, 2017-2032 (USD Million)
TABLE 292. France Guided Tissue & Bone Regeneration Membranes Market Size, 2017-2032 (USD Million)
TABLE 293. France Guided Tissue & Bone Regeneration Membranes Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 294. France Guided Tissue & Bone Regeneration Membranes Market Size, by Non-Resorbable, 2017-2032 (USD Million)
TABLE 295. France Guided Tissue & Bone Regeneration Membranes Market Size, by Resorbable, 2017-2032 (USD Million)
TABLE 296. France Guided Tissue & Bone Regeneration Membranes Market Size, by Collagen, 2017-2032 (USD Million)
TABLE 297. France Guided Tissue & Bone Regeneration Membranes Market Size, by Synthetic, 2017-2032 (USD Million)
TABLE 298. France Guided Tissue & Bone Regeneration Membranes Market Size, by Application, 2017-2032 (USD Million)
TABLE 299. France Guided Tissue & Bone Regeneration Membranes Market Size, by End User, 2017-2032 (USD Million)
TABLE 300. France Guided Tissue & Bone Regeneration Membranes Market Size, by Source, 2017-2032 (USD Million)
TABLE 301. France Guided Tissue & Bone Regeneration Membranes Market Size, by Animal Derived, 2017-2032 (USD Million)
TABLE 302. France Guided Tissue & Bone Regeneration Membranes Market Size, by Synthetic, 2017-2032 (USD Million)
TABLE 303. Russia Guided Tissue & Bone Regeneration Membranes Market Size, 2017-2032 (USD Million)
TABLE 304. Russia Guided Tissue & Bone Regeneration Membranes Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 305. Russia Guided Tissue & Bone Regeneration Membranes Market Size, by Non-Resorbable, 2017-2032 (USD Million)
TABLE 306. Russia Guided Tissue & Bone Regeneration Membranes Market Size, by Resorbable, 2017-2032 (USD Million)
TABLE 307. Russia Guided Tissue & Bone Regeneration Membranes Market Size, by Collagen, 2017-2032 (USD Million)
TABLE 308. Russia Guided Tissue & Bone Regeneration Membranes Market Size, by Synthetic, 2017-2032 (USD Million)
TABLE 309. Russia Guided Tissue & Bone Regeneration Membranes Market Size, by Application, 2017-2032 (USD Million)
TABLE 310. Russia Guided Tissue

Companies Mentioned

  • ACE Surgical Supply Company, Inc.
  • BEGO GmbH & Co. KG
  • BioHorizons, Inc.
  • Bioteck S.P.A.
  • Botiss biomaterials GmbH
  • Cologenesis Healthcare Private Limited
  • DENTSPLY SIRONA Inc.
  • Geistlich Pharma AG
  • Integra LifeSciences Holdings Corporation
  • Keystone Dental, Inc.
  • Neoss Limited
  • Nobel Biocare Services AG
  • OraPharma, Inc.
  • Straumann Holding AG
  • Sunstar Suisse S.A.
  • Yantai Zhenghai Bio-tech Co., Ltd.